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Chronic Obstructive Pulmonary Disease (COPD) is usually characterized by a progressive decline of lung
function. We reported the 10 years follow-up of an elderly man, a heavy smoker with severe COPD and
apical bullous emphysema. During 6 months pulmonary rehabilitation program the patient’s clinical
state improved signiﬁcantly and it associated with a steep increase in forced expiratory volume in one
second (FEV1). This case report elaborates on the unexpected gain of FEV1 in the follow-up of a COPD
patient.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The primary pathophysiologic characteristic of Chronic
Obstructive Pulmonary Disease (COPD) is airﬂow limitation caused
by airway narrowing and loss of elastic recoil [1]. As the disease has
a progressive nature, FEV1 usually declines over time [2]. So far,
most treatments offer signiﬁcant symptom improvements,
reducing the frequency of exacerbations yet it does not affect the
lung function decline, with the exception of smoking cessation [3].
In the management of COPD pulmonary rehabilitation plays a
major role, as it has been shown to improve the quality of life,
exercise capacity and symptoms on top of pharmacological treat-
ment [4]. However, there is no evidence corroborating improve-
ments in lung function with undertaking a pulmonary
rehabilitation program. We report a case of a severe COPD patient
whose pulmonary function improved signiﬁcantly after following
such a program.2. Case report
A 66-year-old manwith a smoking history of 18-pack-years was
diagnosed with COPD in 1997. The man was treated with then, Belgium.
nssens).
Ltd. This is an open access article ustandard inhalation therapy and smoking cessation one year after.
At the time of diagnosis, lung function presented a forced vital
capacity (FVC) of 3,56 L (81%pred.), forced expiratory volume in one
second (FEV1) of 1,51 L (42%pred.), a FEV1/FVC ratio of 0.42, total
lung capacity (TLC) of 6,63 L (96%pred.), a residual volume (RV) of
3,01 L (138%pred.) and a diffusing capacity (TLco) of 47%pred.
Computed Tomography (CT) of the chest demonstrated diffuse
emphysema with large apical bullae most pronounced in the left
hemi-thorax. During yearly follow-up, the patient was reporting a
stable dyspnea, particularly during moderate to intense physical
activities (mMRC 2). There were no exacerbations. The repetitive
pulmonary function tests demonstrated an expected further
decline of FEV1 under maintenance therapy with long-acting B2
agonists and inhaled corticosteroids.
In September 2007, the patient was admitted to the hospital for
bilateral pneumonia (most pronounced in the right middle lobe) for
which he was successfully treated 3with conventional antibiotics
during 7 days. Long-acting anticholinergics were added to the
therapy. After discharge, the patient joined a pulmonary rehabili-
tation program for 6 months during which his clinical status
drastically improved. Maximal exercise capacity at the start of the
program (Watt: 60, VO2: 1173 ml/min, FEV1: 1.16 L, VEmax: 41 L/
min) increased by more than 50% after 6 months training (Watt:
110, VO2: 1839 ml/min, FEV1:1.89 L, VEmax: 62 L/min). The 6 mi-
nutes walking distance increased with 205 m (from 401 m to
606 m).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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further follow-up. The FEV1 of 2.04 L or 62%predicted at that time
was recorded and further maintained for the next 5 years (Fig. 1).
At the outpatient clinic, a junior doctor reported on the letter to
the GP that rehabilitation resulted in clinically signiﬁcant im-
provements in pulmonary function and exercise capacity. This
statement may not be correct.3. Discussion
“Pulmonary rehabilitation is a comprehensive intervention
based on a thorough patient assessment followed by patient-
tailored therapies, which include, but are not limited to, exercise
training, education, and behavior change, designed to improve the
physical and psychological condition of people with chronic res-
piratory disease” [5]. A Cochrane review including 31 randomized
controlled trials in COPD found clinically and statistically signiﬁcant
improvements in exercise capacity and quality of life following
rehabilitation. On average the expected increase in VO2 is 10e20%
of baseline and between 32 and 65 m for the 6 minutes walking
distance [6]. Hence, there are no data supporting a raise in FEV1. In
our case we observed a gain in lung function, maximal exercise
capacity and 6 minutes walking test beyond all expectations.Fig. 1. Evolution of spirometry in time, with denotation of the 6-month period during which
Expiratory Volume. RV ¼ Residual Volume. TLC ¼ Total lung volume (data are presented as p
throughout whole period).Although the effects of training on an individual may be much
larger than the group average, most of the effect should be attrib-
uted to the larger maximal ventilation by a steep increase in FEV1.
The latter is not explained by a spontaneous recovery of FEV1 post
pneumonia, as baseline FEV1 values have been continuously lower
for 10 consecutive years prior to the event.
If we take a closer look at lung function changes, deﬂation with
the characteristic drop of RV and a corresponding increase in FVC
and FEV1 occurred within a stable TLC. Although one may assume
that the introduction of Tiotropium in the maintenance therapy
resulted in static deﬂation, the magnitude of this response (almost
1.0 L) is too large to be true. Mean improvements in FEV1 with
Tiotropium on top of LABA/ICS combinations are normally between
60 and 100ml and although the individual effect-size may be much
larger, other possibilities need to be considered [7]. We would
recommend checking the X-rays, as we think of autobullectomy.
X-rays and CT scan conﬁrmed our hypothesis; the giant bulla
earlier seen in the right upper lobe disappeared (Fig. 2). Usually,
pulmonary bullae gradually enlarge and spontaneous regression is
very rare [8]. A Pubmed search revealed only 8 relevant articles
with reference to the spontaneous resolution of pulmonary bullae,
most often due to infection of the bulla (bullitis), leading to an
autobullectomy. The assumption for the autobullectomy hypothesispulmonary rehabilitation was undertaken. FVC ¼ Forced Vital Capacity; FEV1 ¼ Forced
ercent of predicted, ECSC values; lung volumes are measured by body plethysmography
Fig. 2. A/X-ray of the chest before and after the pneumonia. B/CT images of the apical bullae before the infectious episode. C/Corresponding CT images 4 years after the infectious
event.
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M. Topalovic et al. / Respiratory Medicine Case Reports 18 (2016) 81e8484is an inﬂammatory process (e.g. infection, tumor, blood clot) within
the bulla leading to obstruction of the supplying bronchus and
subsequent collapse.
Bullectomy should be considered when the hyperinﬂation is
thought to contribute to dyspnea and exercise limitation. Other
indications for surgical bullectomy are complications: hemoptysis,
recurrent pneumothorax, and infectious bullitis. In the absence of
any complication, experts recommend surgical bullectomy only
when the bulla takes at least one third, preferably one-half, of the
hemithorax [9]. In 2001, bullectomy was considered but not per-
formed in our patient because of limited complaints and subjective
wellbeing. In retrospect, given subjective and objective improve-
ments in dyspnea and exercise capacity after autobullectomy, we
may conclude that surgical bullectomy at the time of diagnosis
would have been a good treatment option.
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